Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
about
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.Micafungin in invasive fungal infections in children with acute leukemia or undergoing stem cell transplantation.
P2860
Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Safety, tolerability, and feas ...... tic stem cell transplantation.
@en
Safety, tolerability, and feas ...... tic stem cell transplantation.
@nl
type
label
Safety, tolerability, and feas ...... tic stem cell transplantation.
@en
Safety, tolerability, and feas ...... tic stem cell transplantation.
@nl
prefLabel
Safety, tolerability, and feas ...... tic stem cell transplantation.
@en
Safety, tolerability, and feas ...... tic stem cell transplantation.
@nl
P2093
P2860
P1433
P1476
Safety, tolerability, and feas ...... tic stem cell transplantation.
@en
P2093
K Hirabayashi
K Sakashita
K Yoshikawa
R Yanagisawa
T Shigemura
Y Katsuyama
Y Nakazawa
P2860
P2888
P304
P356
10.1007/S15010-014-0601-9
P577
2014-02-25T00:00:00Z